Table 2 Mucinous differentiation in relation to patient survival.
Colorectal cancer-specific survival | Overall survival | ||||||
|---|---|---|---|---|---|---|---|
No. of cases | No. of events | Univariable HR (95% CI) | Multivariable HR (95% CI) | No. of events | Univariable HR (95% CI) | Multivariable HR (95% CI) | |
All patients | |||||||
Mucinous differentiation | 1049 | 292 | 525 | ||||
0% | 668 | 178 | 1 (referent) | 1 (referent) | 317 | 1 (referent) | 1 (referent) |
1–50% | 296 | 86 | 1.14 (0.88–1.48) | 0.99 (0.76–1.30) | 158 | 1.20 (0.99–1.45) | 1.00 (0.82–1.22) |
>50% | 85 | 28 | 1.36 (0.91–2.02) | 1.35 (0.89–2.04) | 50 | 1.39 (1.03–1.87) | 1.34 (0.98–1.82) |
Ptrend | 0.099 | 0.317 | 0.010 | 0.178 | |||
MMR-proficient | |||||||
Mucinous differentiation | 889 | 263 | 444 | ||||
0% | 619 | 169 | 1 (referent) | 1 (referent) | 292 | 1 (referent) | 1 (referent) |
1–50% | 211 | 69 | 1.29 (0.97–1.70) | 1.00 (0.75–1.33) | 111 | 1.22 (0.98–1.51) | 0.97 (0.78–1.22) |
>50% | 59 | 25 | 1.87 (1.23–2.84) | 1.36 (0.88–2.11) | 41 | 1.80 (1.30–2.50) | 1.32 (0.94–1.85) |
Ptrend | 0.002 | 0.332 | 0.0004 | 0.311 | |||
MMR-deficient | |||||||
Mucinous differentiation | 160 | 29 | 81 | ||||
0% | 49 | 9 | 1 (referent) | 1 (referent) | 25 | 1 (referent) | 1 (referent) |
1–50% | 85 | 17 | 1.01 (0.45–2.27) | 1.34 (0.50–3.57) | 47 | 1.04 (0.64–1.68) | 1.00 (0.56–1.77) |
>50% | 26 | 3 | 0.54 (0.15–2.00) | 1.55 (0.35–6.75) | 9 | 0.61 (0.29–1.31) | 0.93 (0.40–2.17) |
Ptrend | 0.442 | 0.506 | 0.304 | 0.887 | |||
